Thursday, August 3, 2006
  • Vol 12, Issue 15
  • Julie McElrath
    Dr. Julie McElrath, Clinical Research Division, will receive $30.1 million to lead a consortium dedicated to testing the effectiveness of adjuvants — compounds which can enhance cellular immune responses and aid HIV-vaccine development.
    Photo by Jim Linna

    Science Articles
    General Articles
    Briefs

    Credits


    Fred Hutchinson Cancer Research Center
    1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
    ©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
    Terms of Use & Privacy Policy.